Cetrolix 0.25mg Injection Description:
In females undergoing treatment for infertility, sometimes premature ovulation can lead to the release of eggs which are not ready for fertilisation. Cetrolix 0.25mg Injection blocks the action of a natural hormone and prevents premature release of the eggs from the ovary. In males, Cetrolix 0.25mg Injection lowers the amount of testosterone (a male hormone) produced by the body. This may slow or stop the spread and growth of prostate cancer cells that need testosterone to grow.
Cetrolix 0.25mg Injection is used in the treatment of female infertility.
Headache, Nausea, Abdominal pain, Injection site reaction, Ovarian hyperstimulation syndrome.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How does Cetrolix work?
Cetrolix works in combination with other hormonal therapies during assisted reproductive treatment in women to prevent release of eggs from the ovaries.
Buy Cetrolix 0.25mg Injection Online From India At Best Price
If you are looking to buy Cetrorelix (0.25mg) (1 Injection in 1 vial) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Cetrolix 0.25mg Injection in –
South East Asia – China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) – Iran, Saudi Arabia, Jordan.
North America – Venezuela, USA (United States of America), Suriname.
South America – Argentina, Chile, Colombia, Peru, Venezuela.
Europe – Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS – Moldova, Uzbekistan, Kyrgyzstan.
African Countries – Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries – Malaysia, Egypt, Australia, Italy and New Zealand.